Related Experiment Videos

Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumors

Kate O Wright1, Edward M Messing, Jay E Reeder

  • 1Department of Pathology, University of Rochester, New York, USA.

The Journal of Urology
|November 21, 2002
PubMed
Abstract

Insights

The tumor suppressor gene DBCCR1 (deleted in bladder cancer chromosome region 1) interacts with ASML3a. This discovery offers insights into their roles in bladder cancer development and function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The function of the tumor suppressor gene DBCCR1 (deleted in bladder cancer chromosome region 1) remains unknown.
  • DBCCR1's role in bladder tumorigenesis is supported by data, but it lacks defined protein family or functional pathway classification.
  • Protein-protein interactions are fundamental to cellular functions, making the identification of DBCCR1 binding partners crucial for understanding its role.

Purpose of the Study:

  • To identify DBCCR1 protein binding partners to elucidate its function.
  • To investigate the functional significance of DBCCR1 in bladder cancer.

Main Methods:

  • Yeast two-hybrid system screening of an adult human bladder cDNA library.
  • Identification of DBCCR1 interacting proteins.

Main Results:

  • Acid sphingomyelinase-like phosphodiesterase 3a (ASML3a) was identified as a novel DBCCR1 binding partner.
  • DBCCR1 overexpression up-regulates ASML3a RNA and protein expression in human bladder tumor cell lines.
  • ASML3a protein showed differential expression in 8 out of 12 bladder tumors compared to normal urothelial tissue.

Conclusions:

  • DBCCR1 and ASML3a appear to be involved in bladder tumorigenesis.
  • The interaction between DBCCR1 and ASML3a may provide critical clues to their respective functions in cancer development.

Related Concept Videos